StockWatch
·
Medical/Dental Instruments
RegulatoryJun 24, 2026, 09:46 AM

Femasys Regains Nasdaq Compliance After Reverse Stock Split

AI Summary

Femasys Inc. announced it has regained compliance with Nasdaq's minimum bid price requirement for continued listing. The company received formal notice from Nasdaq on June 23, 2026, confirming that the matter is now closed. This follows a 1-for-20 reverse stock split on June 5, 2026, after which the stock maintained a bid price of $1.00 or more for 10 consecutive business days. CEO Kathy Lee-Sepsick stated that regaining compliance is an important development for Femasys and its shareholders, allowing the company to focus on advancing its strategic priorities.

Key Highlights

  • Femasys Inc. received notice on June 23, 2026, confirming compliance with Nasdaq Listing Rule 5550(a)(2).
  • The company previously failed to maintain a minimum bid price of $1.00 per share.
  • Compliance was regained following a 1-for-20 reverse stock split effective June 5, 2026.
  • The common stock's closing bid price remained at or above $1.00 for 10 consecutive business days.
  • CEO Kathy Lee-Sepsick emphasized the importance of regaining compliance for shareholders and strategic focus.